Part of the book series:Handbook of Experimental Pharmacology/Handbuch der experimentellen Pharmakologie ((HEP,volume 19))
178Accesses
192Citations
Abstract
Quantitative data on the occurrence of 5-HT and related indolealkylamines in nature are presented in Tables 1–23 of this chapter and in Tables 1–6 of chapter 13. The interest of these data is obvious, especially for the interpretation of the physiological significance of indolealkylamines in their different localizations. However, it seems opportune to call attention at once to a few points.
This is a preview of subscription content,log in via an institution to check access.
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, books and news in related subjects, suggested using machine learning.References
Adam, K. R., and C.Weiss: 5-Hydroxytryptamine in scorpion venom. Nature (Lond.)178, 421–422 (1956).
Adam, K. R., and C.Weiss: Distribution of 5-hydroxytryptamine in scorpion venoms. Nature (Lond.)183, 1398–1399 (1959).
Adams, B. G.: Serum 5-hydroxytryptamine levels following experimental increase in gastrointestinal activity in man. Lancet 1960I, 207–208.
Adams-Ray, J., A.Dahlström, K.Fuxe, and N.-Å.Htllarp: Mast cells and monoamines. Experientia (Basel)20, 80–82 (1964).
Aiello, E. L.: Identification of the cilioexcitatory substance present in the gill of the musselMytilus edulis. J. cell. comp. Physiol.60, 17–21 (1962).
Airaksinen, M. M., and V. J.Uuspää: Is urinary 5-hydroxytryptamine formed in the kidney? Biochem. Pharmacol.8, 46 (1961).
Albrecht, P., M. B.Visscher, J. J.Bittner and F.Halberg: Daily changes in 5-hydroxytryptamine concentration in mouse brain. Proc. Soc. exp. Biol. (N.Y.)92, 703–706 (1956).
Amin, A. H., T. B. B.Crawford and J. H.Gaddum: The distribution of substance P and 5-hydroxytryptamine in the central nervous system of the dog. J. Physiol. (Lond.)126, 596–618 (1954).
Anastasi, A., and V.Erspamer: Occurrence and some properties of eledoisin in extracts of posterior salivary glands of eledone. Brit. J. Pharmacol.19, 326–336 (1962).
Anderson, E. G., and D. D.Bonnycastle: A study of the central depressant action of pentobarbital, phenobarbital and diethyl ether in relationship to increases in brain 5-hydroxytryptamine. J. Pharmacol. exp. Ther.130, 138–143 (1960).
Anderson, E. G., and J.Cudia: The anatomical localization of norepinephrine and 5-hydroxytryptamine in cat spinal cord. Fed. Proc.21, 341 (1962).
Anderson, E. G., S. D.Markowitz and D. D.Bonnycastle: Brain 5-hydroxytryptamine and anticon-vulsant activity. J. Pharmacol. exp. Ther.136, 179–182 (1962).
Anderson, J. A., M. R.Ziegler and D.Doeden: Banana feeding and urinary excretion of 5-hydroxyindoleacetic acid. Science127, 236–238 (1958).
Antonelli, A. R., G.Bertaccini and P.Mantegazzini: Relationship between mesencephalic and hypothalamic concentration of 5-hydroxytryptamine and cortical electrical activity of cats. J. Neurochem.8, 157–158 (1961).
Aprison, M. H., M. A.Wolf, G. L.Poulos and T. L.Folkerth: Neurochemical correlates of behavior. III. Variation of serotonin content in several brain areas and peripheral tissues of the pigeon following 5-hydroxytryptophan administration. J. Neurochem.9, 575–584 (1962).
Armin, J., and R. T.Grant: Further observations on vasoconstrictor substances in blood of rabbit and man. J. Physiol. (Lond.)138, 401–416 (1957).
Armstrong, M. D., K. N. F.Shaw, M. J.Gortawski and H.Singer: The indole acids of human urine. Paper chromatography of indole acids. J. biol. Chem.232, 17–30 (1958).
Ashcroft, G. W., and D. F.Sharman: 5-Hydroxyindoles in human cerebrospinal fluid. Nature (Lond.)186, 1050–1051 (1960).
Ashcroft, G. W., and D. F.Sharman: The effect of reserpine on the concentration of 5-OR indolyl compounds in the caudate nucleus and the cerebrospinal fluid of the dog. J. Physiol. (Lond.)158, 32–33 P (1961).
Ashcroft, G. W., and D. F.Sharman: Drug-induced changes in the concentration of 5-OR indolyl compounds in cerebrospinal fluid and caudate nucleus. Brit. J. Pharmacol.19, 153–160 (1962).
Axelrod, J., R. J.Wttrtman, and CH. M.Winget: Melatonin synthesis in the hen pineal gland and its control by light. Nature (Lond.)201, 1134 (1964).
Barac., G.: Elimination rénale de l’acide 5-hydroxyindoleacétique chez le Chien. C. R. Soc. Biol. (Paris)155, 1732–1734 (1961).
Barbeau, A., et G.Jasmin: Dosage de l’acide 5-hydroxyindoleacétique urinaire dans la maladie de Parkinson. Rev. canad. Biol.20, 837–838 (1961).
Barchas, J. D., and D. X.Freedman: Brain amines: response to physiological stress. Biochem. Pharmacol.12, 1232–1235 (1963).
Barchas, J. D., and A. B.Lerner: Localization of melatonin in the nervous system. J. Neurochem.11, 489–491 (1964).
Bartlet, A. L.: The 5-hydroxytryptamine content of mouse brain and whole mice after treatment with some drugs affecting the central nervous system. Brit. J. Pharmacol.15, 140–146 (1960).
Barchas, J. D.: The influence of chlorpromazine on the excretion of 5-hydroxyindoleacetic acid from mice. J. Physiol. (Lond.)165, 25–26 P (1963).
Beaver, M. H., and B. S.Wostmann: Histamine and 5-hydroxytryptamine in the intestinal tract of germ-free animals, animals harbouring one microbial species and conventional animals. Brit. J. Pharmacol.19, 385–393 (1962).
Benditt, E. P.: 5-Hydroxytryptamine and 5-hydroxytryptophan decarboxylase in rat mast cells. In: G. P.Lewis (Ed.), 5-Hydroxytryptamine, p. 31–34. London: Pergamon Press 1957.
Benditt, E. P., S.Bader and K. B.Lam: Studies of the mechanisms of acute vascular reactions to injury. Arch. Path.60, 104–115 (1955a).
Benditt, E. P., J.Holcenberg, and D.Lagunoff: The role of serotonin (5-hydroxytryptamine) in mast cells. Ann. N.Y. Acad. Sci.103 (3), 179–184 (1963).
Benditt, E. P., R. L.Wong, M.Arase and E.Roeper: 5-Hydroxytryptamine in mast cells. Proc. Soc. exp. Biol. (N.Y.)90, 303–304 (1955b).
Bertaccini, G.: Osservazioni sul contenuto in 5-idrossitriptamina di vari tessuti del ratto durante lo sviluppo postnatale. Ric. Sci.28, 2261–2263 (1958).
Bertaccini, G.: Effect of convulsant treatment on the 5-hydroxytryptamine content of brain and other tissues of the rat. J. Neurochem.4, 217–222 (1959).
Bertaccini, G.: Tissue 5-hydroxytryptamine and urinary 5-hydroxyindoleacetic acid after partial or total removal of the gastro-intestinal tract in the rat. J. Physiol. (Lond.)153, 239–249 (1960).
Bertaccini, G.: Discussion. In: S. S.Kety and J.Elkes (Eds.), Regional Neurochemistry, p. 305–306. London: Pergamon Press 1961.
Bertaccini, G., e R.Cheli: Considerazioni sulla eliminazione urinaria di acido 5-idrossiindolilacetico nel bovino. Arch. Sci. biol. (Bologna)47, 336–338 (1964).
Bertaccini, G., and S.Chieppa: Urinary excretion of 5-hydroxyindoleacetic acid after removal of the large intestine in man. Lancet 1960I, 881.
Bertaccini, G., and V.Erspamer: The effect of the administration of water or isotonic NaCl solution on the urinary excretion of 5-hydroxyindoleacetic acid in the rat. J. Pharm. Pharmacol.14, 687–697 (1962).
Bertaccini, G., and M. B.Nobili: Effect of L-tryptophan on diuresis and 5-hydroxyindoleacetic acid excretion in the rat. Brit. J. Pharmacol.17, 519–525 (1961).
Bettendorf, G., A. P.Moje u. H.-J.Schmermund: Der Einfluß der Strahlenbehandlung auf die 5-Hydroxy-Indol-Essigsäure-Ausscheidung. Strahlentherapie117, 370–376 (1962).
Bhatt, K. G. S., H. R. K.Arora, H. L.Dhar and R. K.Sanyal: Changes in serotonin content in the heart following acute myocardial infarction in the dog. Med. exp.9, 46–48 (1963).
Bhattacharya, B. K., and G. P.Lewis: The release of 5-hydroxytryptamine by histamine liberators. Brit. J. Pharmacol.11, 202–208 (1956).
Bhoola, K. D., J. D.Calle and M.Schachter: The identification of acetylcholine, 5-hydroxytryptamine and other substances in hornet venom. J. Physiol. (Lond.)151, 35–36P (1960).
Bhoola, K. D., J. D.Calle and M.Schachter: Identification of acetylcholine, 5-hydroxytryptamine, histamine, and a new kinin in hornet venom (V. crabro). J. Physiol. (Lond.)159, 167–182 (1961).
Bogdanski, D. F., L.Bonomi and B. B.Brodie: Occurrence of serotonin and catechol-amines in brain and peripheral organs of various vertebrate classes. Life Sciences No 1, 80–84 (1963).
Bogdanski, D. F., A.Pletscher, B. B.Brodie and S.Udenfriend: Identification and assay of serotonin in brain. J. Pharmacol. exp. Ther.117, 82–88 (1956).
Bogdanski, D. F., and S.Udenfriend: Serotonin and monoamine oxidase in brain. J. Pharmacol. exp. Ther.116, 7–8 (1956).
Bogdanski, D. F., H.Weissbach and S.Udenfriend: The distribution of serotonin, 5-hydroxytryptophan decarboxylase, and monoamine oxidase in brain. J. Neurochem.1, 272–278 (1957).
Boggs, D. E., R.Rosenberg and H. A.Waisman: Effects of phenylalanine, phenylacetic acid, tyrosine and valine on brain and liver serotonin in rats. Proc. Soc. exp. Biol. (N.Y.)114, 356–358 (1963).
Bonnycastle, D. D., M. F.Bonnycastle and E. G.Anderson: The effect of a number of central depressant drugs upon brain 5-hydroxytryptamine levels in the rat. J. Pharmacol. exp. Ther.135, 17–20 (1962).
Bonnycastle, D. D., N. J.Giarman and M. K.Paasonen: Anticonvulsant compounds and 5-hydroxytryptamine in rat brain. Brit. J. Pharmacol.12, 228–231 (1957).
Boréus, L. O., and B.Westerholm: 5-Hydroxytryptamine in the Schultz-Dale reaction. Acta physiol. scand.56, 17–25 (1962).
Borgert, H., u. K.Keitel: Über die vasokonstriktorischen Substanzen im Blutserum. Biochem. Z.175, 1–7 (1962).
Born, G. V. R., and R. E.Gillson: Studies on the uptake of 5-hydroxytryptamine by blood platelets. J. Physiol. (Lond.)146, 472–491 (1959).
Bowden, K., B. G.Brown and J. E.Batty: 5-Hydroxytryptamine: its occurrence in cow-hage. Nature (Lond.)174, 925–926 (1954).
Bowers jr., M. B.: Stimulation and sensitization of the isolated Venus heart by cerebrospinal fluid. Brit. J. Pharmacol.19, 295–298 (1962).
Bracco, M., e P. C.Curti: Ricerche sulla natura del fattore vasocostrittore delle piastrine. Haematologica37, 721–736 (1953).
Bracco, M., e P. C.Curti: The vasoconstrictor factor of platelets. Experientia (Basel)10, 71–72 (1954).
Bracco, M., e V.Giuliano: Identificazione della 5-OH-triptamina nei trombociti degli uccelli. Experientia (Basel)12, 31–33 (1956).
Brandt, K., H. V.Eitler, H.Hellström u. N.Lofgren: Gramm und zwei Begleiter desselben in Laubblättern von Gerstensorten. Hoppe-Seylers Z. physiol. Chem.235, 37–42 (1935).
Bridges, J. M., M.Baldini, C.Fichera and W.Dameshek: Effect of antiplatelet antibodies on thein vitro uptake of 5-hydroxytryptamine by blood platelets. Nature (Lond.)197, 364–366 (1963).
Brocklehurst, W. E., J. H.Humphrey and W. L. M.Perry: Cutaneous antigen-antibody reactions in the rat. J. Physiol. (Lond.)150, 489–500 (1960).
Brodle, B. A., P. A.Shore and A.Pletscher: Serotonin-releasing activity limited to Rauwolfia alkaloids with tranquilizing action. Science123, 992–993 (1956).
Brodle, B. B., D. F.Bogdanski, and L.Bonomi: Formation, storage and metabolism of serotonin (5-hydroxytryptamine) and catecholamines in lower vertebrates. In: D.Richter Ed., Comparative Neurochemistry, pp. 367–377. Oxford: Pergamon Press 1964.
Brodle, B. B., S.Spector and P. A.Shore: Interaction of monoamine oxidase inhibitors with physiological and biochemical mechanisms in brain. Ann. N.Y. Acad. Sci.30 (3), 609–616 (1959).
Bruce, D.W.: Serotonin in pineapple. Nature (Lond.)188, 147 (1960).
Bruce, D.W.: Carcinoid tumours and pineapples. J. Pharm. Pharmacol.13, 256 (1961).
Brune, G., and H. E.Himwich: Effects of reserpine on urinary tryptamine and indole-3-acetic acid excretion in mental deficiency, schizophrenia and phenylpyruvic oligophrenia. In: G.Tonini (Ed.), Techniques for the study of psychotropic drugs, p. 176–184. Modena: Soc. Tip. Modenese 1961.
Bülbring, E., and A.Crema: The release of 5-hydroxytryptamine in relation to pressure exerted on the intestinal mucosa. J. Physiol. (Lond.)146, 18–28 (1959a).
Bülbring, E., and A.Crema: The action of 5-hydroxytryptamine, 5-hydroxytryptophan and reserpine on peristalsis in anaesthetized guinea-pigs. J. Physiol. (Lond.)146, 29–53 (1959b).
Bulard, C., and A. C.Leopold: 5-Hydroxytryptamine chez les plantes supérieures. C. R. Acad. Sci. (Paris)247, 1282–1284 (1958).
Cambridge, G. W., and J. A.Holgate: 5-HT in plasma. J. Physiol. (Lond.)142, 53–54P (1958).
Cardot, J.: Mise en évidence de la tryptamine dans les extraits nerveux du MollusqueHelix pomatia. C. R. Soc. Biol. (Paris)157, 853–854 (1963).
Cardot, J., et J.Ripplinger: Recherches sur les amines indoliques cardio-actives présentes dans le tissue nerveux du mollusqueHelix pomatia. J. Physiol. (Paris)55, 217–218 (1963).
Cardot, J., et J.Ripplinger, et M.Lonchampt: Sur la non spécificité tissulaire des acides aminés basiques et des amines chez l’Escargot (Helix pomatia L.) C. R. Soc. Biol. (Paris)156, 1433–1435 (1962).
Carlini, E. A., and J. P.Green: The subcellular distribution of histamine, slow-reacting substance and 5-hydroxytryptamine in the brain of the rat. Brit. J. Pharmacol.20, 264–277 (1963).
Carlisle, D. B.: An indole-alkylamine regulating heart-beat in Crustacea. Biochem. J.63, 32–33P (1956).
Carlisle, D. B.: On the venom of the lesser weeverfish, Trachinus vipera. J. mar. biol. Ass. U. Kingd.42, 155 (1962).
Carlisle, D. B.: The neurohumoral control of heart rate in crustaceans. In: D.Richter Ed., Comparative Neurochemistry, pp. 323–328. Oxford: Pergamon Press 1964.
Carlisle, D. B., and F.Knowles: Endocrine control in Crustacea, p. 72. Cambridge: Cambridge University Press 1959.
Carlsson, A., T.Magnusson and E.Rosengren: 5-Hydroxytryptamine of the spinal cord normally and after transection. Experientia (Basel)19, 359 (1963).
Cass, R., and P. B.Marshall: Effect of adrenocortical hormones on tissue histamine and 5-hydroxytryptamine in the rat. Arch. int. Pharmacodyn.136, 311–332 (1962).
Cerhova, M., A.Sidlova and A.Zeleny: The effect of skin inflammation on blood content of serotonin and histamine. Physiol. bohemoslov.11, 136–141 (1962).
Cerletti, A.: Über Vorkommen und Bedeutung der Indolstruktur in der Medizin und Biologie. Progr. Drug Res.2, 227–249 (1960).
Chieco Blanchi, L., L.Fiore Donati, N.Pennelli and G.Bertaccini: Mast cell reaction and 5-hydroxytryptamine content in the skin of Syrian golden hamsters painted with 9:10-dimethyl-l:2-benzanthracene. Nature (Lond.)199, 293–294 (1963).
Clark, W. G.: Amine content and biosynthesis in mastocytomas and Octopus salivary glands. Fed. Proc.19, 9 (1960).
Colhoun, E. H.: Synthesis of 5-hydroxytryptamine in the American cockroach. Experientia (Basel)19, 9–10 (1963).
Colhoun, E. H.: Aspects of biologically active substances in insects with particular reference to the cockroach,Periplaneta americana. In: D.Richter Ed., Comparative Neurochemistry, pp. 333–339. Oxford: Pergamon Press 1964.
Correale, P.: The occurrence and distribution of 5-hydroxytryptamine (enteramine) in the central nervous system of vertebrates. J. Neurochem.1, 22–31 (1956).
Costa, E., and M. H.Aprison: Distribution of intracarotidly injected serotonin in the brain. Amer. J. Physiol.192, 95–100 (1958).
Coupland, R. E., and I. D.Heath: Chromaffin cells, mast cells and melanin. II. The chromaffin cells of the liver capsule and gut in ungulates. J. Endocr.22, 71–76 (1961).
Coupland, R. E., and J. F.Riley: Mast cells and 5-hydroxytryptamine in precancerous mouse skin. Nature (Lond.)187, 1128–1129 (1960).
Crawford, N.: Plasma free serotonin (5-hydroxytryptamine). Clin. chim. Acta8, 39–45 (1963).
Crout, J. R., and A.Sjoerdsma: The clinical and laboratory significance of serotonin and catechol amines in bananas. New Engl. J. Med.261, 23–26 (1959).
Culley, W. J., R. X.Sauxders, E. T.Mertz and D. H.Jolly: Plasma tryptophan and brain serotonin levels of rats fed a tryptophan deficient diet. Fed. Proc.22, 203 (1963);— Proc. Soc. exp. Biol. (N.Y.)113, 645-648 (1963).
Dalgliesh, C. E., C. C.Toh and T. S.Work: Fractionation of the smooth muscle stimulants present in extracts of the gastrointestinal tract. Identification of 5-hydroxytryptamine and its distinction from substance P. J. Physiol. (Lond.)120, 298–310 (1953).
Dannenbourg, W. N., and J. L.Livermax: Conversion of tryptophan-2-C14 to indoleacetic acid by watermelon tissue slices. Plant Physiol.32, 263–269 (1957).
Davey, K. G.: A pharmacologically active agent in the reproductive system of insects. Canad. J. Zool.38, 39–45 (1960).
Davies, D. F., K.M.Wolfe and H. M.Perry: Studies on primary amines. II. Their natural occurrence in urine of normotensive and hypertensive patients. J. Lab. clin. Med.43, 620–632 (1954).
Davis, R. B., W. R.Meeker jr. and W. L.Bailey: Serotonin release by bacterial endotoxin. Proc. Soc. exp. Biol. (N.Y.)108, 774–776 (1961).
Day, S., and J. P.Green: Levels of heparin, histamine and 5-hydroxytryptamine in neoplastic mast cells in vivo. Fed. Proc.18, 381 (1959).
Degkwitz, R., R.Froweix, E.Kirberger, C.Kulenkampff u. U.Mohs: Über Normal-werte der stündlichen 5-HIES-Ausscheidung im Urin beim Menschen und die Messungen störender Faktoren. Klin. Wschr.40, 285–289 (1962).
Degkwitz, R., O.Schulenburg u. H.Sieroslawski: Die 5-HIES-Ausscheidung im Urin beim Schlafen und Wachen. Klin. Wschr.42, 102–103 (1964).
DeIraldi, A. P., and E. DeRobertis: Action of reserpine on the submicroscopic morphology of the pineal gland. Experientia (Basel)17, 122–124 (1961).
DeIraldi, A. P., L. M.Zieher and E. DeRobertis: The 5-hydroxytryptamine content and synthesis of normal and denervated pineal gland. Life Sci.9, 691–696 (1963).
Delay, J., P.Pichon et T.Lamperiere: La psilocybine (Historique-Pharmacophysiologie-Clinique). Presse méd.67, 1731–1733 (1959).
Despopoulos, A.: Renal metabolism of 5-hydroxyindole acetic acid. Fed. Proc.15, 48 (1956); — Amer. J. Physiol.189, 548-550 (1957).
Deulefeu, V., and B.Berinzaghi: Picrolonates of bufotenine, bufotenidine and dehydro-bufotenine. J. Amer. chem. Soc.68, 1665–1666 (1946).
Donaldson jr., R. M.: Excretion of tryptamine and indole-3-acetic acid in urine of rats with intestinal diverticula. Amer. J. Physiol.202, 289–292 (1962).
Donaldson jr., R. M., H. A.Dolcini and S. J.Gray: Urinary excretion of indolic compounds in rats with intestinal pouches. Amer. J. Physiol.200, 794–796 (1961).
Donaldson jr., R. M., S.Malkiel and S. J.Gray: Serotonin studies on mouse tissues. Proc. Soc. exper. Biol. (N.Y.)103, 261–263 (1960).
Dubnick, B., G. A.Leeson, M.Chessin and CH. C.Scott: Accumulation of serotonin in the brain of reserpine-treated mice after inhibition of monoamine oxidase: effect of body temperature. Arch. int. Pharmacodyn.,126, 194–202 (1960).
Dubnick, B., G. A.Leeson, and G. E.Phillips: An effect of monoamine-oxidase inhibitors on brain serotonin of mice in addition to that resulting from inhibition of monoamine oxidase. J. Neurochem.9, 299–306 (1962).
Eber, O., u. F.Lembeck: Hydroxytryptamingehalt des Rattendarmes bei verschiedenem Tryptophangehalt der Nahrung. Pflügers Arch. ges. Physiol.265, 563–566 (1958).
Edelstein, E. L., Y.Pfeifer, J. E.Steiner and F. G.Sulman: Excretion of urinary 5-HIAA in dog pellagra. Proc. Soc. exp. Biol. (N.Y.)110, 13–16 (1962).
Ehringer, H., O.Hornykiewicz u. K.Lechner: Die Wirkung von Methylenblau auf die Monoaminoxydase und den Katecholamin-und 5-Hydroxytryptaminstoffwechsel des Gehirnes. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak.241, 568–582 (1961).
Eliasson, R.: Critical evaluation of the occurrence of 5-hydroxytryptamine in human semen. J. Urol.86, 676–678 (1961).
Ende, N., and E. I.Cherniss: Mast cells, histamine and serotonin. Amer. J. clin. Path.30, 35–36 (1958).
Enerback, L.: Serotonin in human mast cells. Nature (Lond.)197, 611 (1963).
Ershoff, B. H., and E. M.Gal: Effects of radiation on tissue serotonin levels in the rat. Proc. Soc. exp. Biol. (N.Y.)108, 160–162 (1961).
Ershoff, B. H., R.Hellmers and A. F.Wells: Effects of a radioprotective agent on tissue serotonin levels in the X-irradiated rat. Proc. Soc. exp. Biol. (N.Y.)110, 536–538 (1962).
Erspamer, V.: Pharmakologische Studien über Enteramin. I. Über die Wirkung von Aceton-extrakten der Kaninchenmagenschleimhaut auf den Blutdruck und auf isolierte überlebende Organe. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak.196, 343–365 (1940a).
Erspamer, V.: Pharmakologische Studien über Enteramin. III. Über das Vorhandensein eines enteramin-ähnlichen Stoffes in Milzextrakten. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak.196, 391–407 (1940b).
Erspamer, V.: Presenza di enteramina o di una sostanza enteraminosimile negli estratti gastrointestinali e splenici dei pesci e negli estratti gastroenterici délie ascidie. Experientia (Basel)2, 369–371 (1946).
Erspamer, V.: Ricerche chimiche e farmacologiche sugli estratti di ghiandola ipobranchiale di Murex. IV. Presenza negli estratti di enteramina o di una sostanza enteraminosimile. Arch. int. Pharmacodyn.76, 308–326 (1948a).
Erspamer, V.: Active substances in the posterior salivary glands of octopoda. I. Enteramine-like substance. Acta pharmacol. (Kbh.)4, 213–223 (1948b).
Erspamer, V.: Über den 5-Hydroxytryptamin-(Enteramin-) Gehalt des Magen-Darmtraktes bei den Wirbeltieren. Naturwissenschaften40, 318–319 (1953).
Erspamer, V.: Il sistema cellulare enterocromaffine e l’enteramina (5-idrossitriptamina). Rend. sci. Farmitalia1, 1–193 (1954 a).
Erspamer, V.: Pharmacology of indolealkylamines. Pharmacol. Rev.6, 425–487 (1954 b).
Erspamer, V.: Quantitative estimation of 5-hydroxytryptamine in gastrointestinal tract, spleen and blood of vertebrates. Ciba Foundation, Symposium on Hypertension, p. 78–84. London: Churchill 1954 c.
Erspamer, V.: Isolation of bufoviridine from the skin ofBufo viridis and its identification as dihydro-bufothionine. Biochem. Pharmacol.2, 270–275 (1959a).
Erspamer, V.: Isolation of leptodactyline (m-hydroxyphenylethyltrimethylammonium) from extracts ofLeptodactylus skin. Arch. Biochem. Biophys.82, 431–438 (1959b).
Erspamer, V., and B.Asero: Isolation of enteramine from extracts of posterior salivary glands ofOctopus vulgaris andDiscoglossus pictus skin. J. biol. Chem.200, 311–318 (1953).
Erspamer, V., G.Bertaccini and J. M.Cei: Occurrence of an eleidosin-like polypeptide (physalaemin) in skin extracts ofPhysalaemus fuscumaculatus. Experientia (Basel)18, 562–563 (1962 a).
Erspamer, V., G.Bertaccini and J. M.Cei: Occurrenc3 of bradykinin-like substances in the amphibian skin. Experientia (Basel)18, 563–564 (1962b).
Erspamer, V., and G.Boretti: Identification and characterization, by paper chromatography, of enteramine, octopamine, tyramine, histamine and allied substances in extracts of posterior salivary glands of octopoda and in other tissue extracts of vertebrates and invertebrates. Arch. int. Pharmacodyn.88, 296–332 (1951).
Erspamer, V., u. R.Faustini: Über den 5-Hydroxytryptamin-(Enteramin-, Serotonin-) Gehalt des Serums und des Milzgewebes bei Wirbeltieren sowie der Hämolymphe bei Octopoden. Naturwissenschaften40, 317–318 (1953).
Erspamer, V., and A.Testini: Observations on the release and turnover rate of 5-hydroxytryptamine in the gastrointestinal tract. J. Pharm. Pharmacol.11, 618–623 (1959).
Erspamer, V., and M.Vialli: Presence of enteramine in the skin of amphibia. Nature (Lond.)167, 1033 (1951).
Erspamer, V., and M.Vialli: Ricerche preliminari sulle indolalchilamine e fenilalchilamine degli estratti di pelle di anfibio. Ric. sci.22, 1420–1425 (1952).
Erspamer, V., T.Vitali, M. L.Roseghini and J. M.Cei: Occurrence of new imidazolealkylamines (spinaceamine and 6-methylspinaceamine) in skin extracts ofLeptodactylus pentadactylus labyrinthicus. Experientia (Basel)19, 346–347 (1963).
Euler, H. v., H.Erdtman u. H.Hellström: Über das Alkaloid Gramin. Ber. dtsch. chem. Ges.69, 743–747 (1936).
Falck, B.: Observations on the possibilities of the cellular localization of monoamines by a fluorescence method. Acta physiol. scand.56, Suppl. 197, 1–25 (1962).
Faustini, R.: The enteric distribution of 5-hydroxytryptamine (enteramine, serotonin) in some large domestic mammals and the appearance of 5-hydroxytryptamine and the entero-chromaffin cell system in the embryonic calf. Amer. J. vet. Res.16, 397–400 (1955).
Feldberg, W., and C. C.Toh: Distribution of 5-hydroxytryptamine (serotonin, enteramine) in the wall of the digestive tract. J. Physiol. (Lond.)119, 352–362 (1953).
Feldman, S., G.Izak and D.Nelken: Blood coagulation studies and serotonin determinations in serum and cerebrospinal fluid in multiple sclerosis. Acta psychiat. scand.32, 37–49 (1957).
Feldstein, A., H.Hoagland and H.Freeman: Blood and urinary serotonin and 5-hydroxyindole acetic acid levels in schizophrenic patients and normal subjects. J. nerv. ment. Dis.129, 62–68 (1959).
Ferrari, V., E.Ginoulhiac e L. T.Tenconi: Osservazioni sperimentali sui derivati 5-idrossiindolici nella carenza da piridossina. Boll. Soc. ital. Biol. sper.33, 1418–1421 (1957).
Feyrter, F.: Über die peripheren endokrinen (parakrinen) Drüsen des Menschen. Wien u. Düsseldorf: Maudrich 1953.
Fiore-Donati, L., G. DeBenedictis, L.Chieco-Bianchi and G.Bertaccini: Development of mast cell reaction during chemical skin carcinogenesis of mouse. Nature (Lond.)193, 287–288 (1962).
Fischer, E., F. A.Vazques, T. A.Fernandez and L.Liskowski: Bufotenin in human urine. Lancet 1961I, 890–891.
Fish, M. S., and E. C.Horning: Studies on hallucmogenetic snuffs. J. nerv. ment. Dis.124, 33–37 (1956).
Fish, M. S., N. M.Johnson and E. C.Horning: Piptadenia alkaloids. Indole bases of P. peregrina (L.) Benth. and related species. J. Amer. chem. Soc.77, 5892–5895 (1955).
Foy, J. M., and J. R.Parratt: A note on the presence of noradrenaline and 5-hydroxytryptamine in plantain (Nusa sapientum var.,paradisiaca). J. Pharm. Pharmacol.12, 360–364 (1960).
Foy, J. M., and J. R.Parratt: 5-Hydroxytryptamine in pinneaples. J. Pharm. Pharmacol.13, 382–383 (1961). Urinary excretion of 5-hydroxyindoleacetic acid in West Africans. Lancet 1962I, 942-943.
Frankland, M., F.Kendricks and M.Greipel: Serotonin concentration in the spleen. Amer. J. dig. Dis.7, 347–355 (1962).
Freedman, D. X.: Effects of LSD-25 on brain serotonin. J. Pharmacol. exp. Ther.134, 160–166 (1961).
Freund, H.: Über die pharmakologischen Wirkungen des defibrinierten Blutes. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak.86, 266–280 (1920).
Frydman, B., and V.Deulofeu: Isolation of 5-hydroxytryptamine from the skin of the toad Bufo arenarum Hensel. Experientia (Basel)17, 545–546 (1961).
Furano, A. V., and J. P.Green: The uptake of biogenic amines by mast cells of the rat. J. Physiol. (Lond.)170, 263–271 (1964).
Furth, J., P.Hagen and E. I.Hirsch: Transplantable mastocytoma in the mouse containing histamine, heparin and 5-hydroxytryptamine. Proc. Soc. exp. Biol. (N.Y.)95, 824–828 (1957).
Gaddum, J. H., and N. J.Giarman: Preliminary studies on the biosynthesis of 5-hydroxytryptamine. Brit. J. Pharmacol.11, 88–92 (1956).
Gal, E. M., and P. A.Drewes: Levels of serotonin during convulsion and the effect of reserpine. Nature (Lond.)189, 234 (1961a).
Gal, E. M., and P. A.Drewes: Studies on the metabolism of 5-hydroxytryptamine (serotonin). I. Effect of starvation and thiamine deficiency. Proc. Soc. exp. Biol. (N.Y.)106, 295–297 (1961b).
Gal, E. M., and P. A.Drewes: Studies on the metabolism of 5-hydroxytryptamine (serotonin). II. Effect of tryptophan deficiency in rats. Proc. Soc. exp. Biol. (N.Y.)110, 368–371 (1962).
Gal, E. M., P. A.Drewes, and C. A.Barraclough: Effect of reserpine and the metabolism of serotonin in tryptophan deficient rats. Biochem. Pharmacol.8, 32 (1961).
Gardner, L. L., and A. A.Tyce: Histamine and related compounds in urticaria pigmentosa: analyses of tissues having mast-cell infiltration. Pediatrics21, 805–812 (1958).
Garven, J. D.: The estimation of 5-hydroxytryptamine in the presence of adrenaline. Brit. J. Pharmacol.11, 66–70 (1956).
Geiger, R. S., N.Cantor and F. A.Gibbs: Localization of monoamines and action of hallucinogens on them in adult mammalian brain cells in long term culture. Fed. Proc.23, 351 (1964).
Gersch, M., F.Fischer, H.Unger u. W.Kabitzer: Vorkommen von Serotonin im Nervensystem vonPeriplaneta americana L. (Insecta). Z. Naturforsch. B16, 351–352 (1961).
Gertner, S. B., M. K.Paasonen and N. J.Giarman: Studies concerning the presence of 5-hydroxytryptamine (serotonin) in the perfusate from the superior cervical ganglion. J. Pharmacol, exp. Ther.127, 268–275 (1959).
Giarman, N. J., and M.Day: Presence of biogenic amines in the bovine pineal body. Biochem. Pharmacol.1, 235 (1958).
Giarman, N. J., and G.Pepeu: Presence of neuro-humors in bovine pineal glands. Fed. Proc.18, 394 (1959).
Giarman, N. J., and D. X.Freedman: Serotonin content of the pineal glands of man and monkeys. Nature (Lond.)186, 480–481 (1960).
Giarman, N. J., and S. L. M.Schanberg: The intracellular distribution of 5-hydroxytryptamine (HT, serotonin) in the rat’s brain. Biochem. Pharmacol.1, 301–306 (1959).
Girard, J.-P.: Le rôle de l’adénosine triphosphorique (ATP) dans la fixation intraplaquettaire de la sérotonine. Schweiz. med. Wschr.93, 1456–1459 (1963).
Gluckman, M. I.: Cerebral free and bound serotonin (5HT) after iproniazid (IIH) and reserpine (R). Fed. Proc.19, 264 (1960).
Görög, P., and L.Szporny: The depleting effect of vincamin on the cerebral serotonin level. Biochem. Pharmacol.11, 165–166 (1962).
Gordon, P.: Changes in blood serotonin during exposure to cold. Nature (Lond.)191, 183–184 (1961).
Gosselin, R. E., K.E.Moore and A. S.Milton: Physiological control of molluscan gill cilia by 5-hydroxytryptamine. J. gen. Physiol.46, 277–296 (1962).
Gottfries, C. G., and T.Magnusson: Excretion of tryptamine in man during treatment with MAO inhibitors. Acta psychiat. scand.38, 223–226 (1962).
Green, H., S. M.Greenberg, R. W.Erickson, J. L.Sawyer and TH.Ellison: Effect of dietary phenylalanine and tryptophan upon rat brain amine levels. J. Pharmacol. exp. Ther.136, 174–178 (1962a).
Green, H., and J. L.Sawyer: Intracellular distribution of serotonin in rat brain. I. Effect of reserpine and the monoamine oxidase inhibitors, tranylcypromine and iproniazid. Arch. int. Pharmacodyn.135, 426–441 (1962).
Green, H., J. L.Sawyer, R. W.Erickson and L.Cook: Effect of repeated oral administration of monoamine oxidase inhibitors on rat brain amines. Proc. Soc. exp. Biol. (N.Y.)109, 347–349 (1962 b).
Green, J. P., and S. M.Day: Heparin, 5-hydroxytryptamine, and histamine in neoplastic mast cells. Biochem. Pharmacol.3, 190–205 (1960b).
Green, J. P., M.Roberts and S. M.Day: Fractionation of heparin from a mast cell tumour of the mouse. Fed. Proc.19, 133 (1960a).
Grette, K.: Determination of 5-hydroxytryptamine with the isolated, perfused pig ear. Acta pharmacol. (Kbh.)13, 177–183 (1957).
Gursey, D., and R. E.Olson: Depression of serotonin and norepinephrine levels in brain stem of rabbit by ethanol. Proc. Soc. exp. Biol. (N.Y.)104, 280–281 (1960).
Gursey, D., J. W.Vester and R. E.Olson: Effect of ethanol administration upon serotonin and norepinephrine levels in rabbit brain. J. clin. Invest.38, 1008–1009 (1959).
Haddox jr., CH. H., and M. S.Saslaw: Urinary 5-methoxytryptamine in patients with rheumatic fever. J. clin. Invest.42, 435–441 (1963).
Haggendal, J., and M.Lindquist: Ineffectiveness of ethanol on noradrenaline, dopamine or 5-hydroxytryptamine levels in brain. Acta pharmacol. (Kbh.)18, 278–280 (1961).
Hagmüller, K., L.Haider u. H.Hellauer: Enterochromaffine Zellen, Serotonin und Zink in der Magen-Darm-Wand des Meerschweinchens und der Maus vor und nach chronischer Zufuhr von Aethanol. Wien. klin. Wschr.73, 834–836 (1961).
Harding-Gaudin, F.: Excrétion urinaire d’acide 5-hydroxyindolylacétique chez le rat albinos carencé ou non en riboflavine. Acta vitamin. (Milano)15, 193–196 (1961).
Hartman, W. J., W. G.Clark, S. D.Cyr, A. L.Jordan and R. A.Leibhold: Pharmacologically active amines and their biogenesis in the octopus. Ann. N.Y. Acad. Sci.90 (3), 637–666 (1960).
Harvey, J. A., A.Heller and R. Y.Moore: The effect of unilateral and bilateral medial forebrain bundle lesions on brain serotonin. J. Pharmacol. exp. Ther.140, 103–110 (1963).
Haverback, B. J., and J. D.Davidson: Serotonin and the gastrointestinal tract. Gastro-enterology35, 570–578 (1958).
Haverback, B. J., F. T.Dutscher, P. A.Shore, E. G.Tomich, L. L.Terry and B. B.Brodie: Serotonin changes in platelets and brain induced by small daily doses of reserpine. Lack of effect of depletion of platelet serotonin in hemostatic mechanisms. New Engl. J. Med.256, 343–345 (1957).
Hawker, R. W., V. S.Roberts and C. F.Walmsley: Some properties of an oxytocic substance in extracts of semen. Endocrinology67, 187–193 (1960).
Hess, S. M., and W.Doepfner: Behavioral effects and brain amine content in rats. Arch. int. Pharmacodyn.134, 89–99 (1961).
Hess, S. M., B. G.Redfield and S.Udenfriend: Tryptamine in animal tissues following administration of iproniazid. Fed. Proc.18, 402 (1959a).
Hess, S. M., B. G.Redfield and S.Udenfriend: The effect of monoamine oxidase inhibitors and tryptophan on the tryptamine content of animal tissues and urine. J. Pharmacol. exp. Ther.127, 178–181 (1959b).
Hess, S. M., and S.Udenfriend: A fluorometric procedure for the measurement of tryptamine in tissues. J. Pharmacol. exp. Ther.127, 175–177 (1959).
Hirose, K.: Relation between the platelet count of human blood and its vasoconstrictor action after clotting. Arch. int. Med.21, 604–612 (1918).
Hochstein, F. A., and A. M.Paradies: Alkaloids of Banisteria caapi and Prestonia amazonicum. J. Amer. chem. Soc.79, 5735–5736 (1957).
Hofmann, A., A.Frey, H.Ott, TH.Petrzilka u. F.Troxler: Konstitutionsaufklärung und Synthese von Psilocybin. Experientia (Basel)14, 397–399 (1958).
Hofmann, A., R.Heim et H.Tscherter: Présence de la psiloeybine dans une espèce européenne d’Agaric, lePsilocybe semilanceata Fr. C. R. Acad. Sci. (Paris)257, 10–12 (1963).
Hofmann, A., and F.Troxler: Identifizierung von Psilocin. Experientia (Basel)15, 101–102 (1959).
Hsia, D. Y.-Y., K.Nishimura and Y.Brenchley: Mechanisms for the decrease of brain serotonin. Nature (Lond.)200, 578 (1963).
Huber, W. G., and R. P.Link: Relationship of serotonin and reserpine in the chicken. Proc. Soc. exp. Biol. (N.Y.)109, 118–120 (1962).
Humphrey, J. H., and R.Jaques: The histamine and serotonin content of the platelets and polymorphonuclear leucocytes of various species. J. Phvsiol. (Lond.)124, 305–310 (1954b).
Humphrey, J. H., and C. C.Toh: Absorption of serotonin (5-hydroxytryptamine) and histamine by dog platelets. J. Physiol. (Lond.)124, 300–304 (1954a).
Iachello, R., E.Riva Sanseverino e A.Urbano: Sulla presenza di 5-idrossitriptamina in estratti di ghiandola sottomascellare di cane. Boll. Soc. ital. Biol. sper.38, 516–518 (1962).
Inouye, A., K.Kataoka and J.Shinagawa: 5-Hydroxytryptamine in the subcellular particles of rabbit brain. Nature (Lond.)194, 286–287 (1962).
Jackson, H. R., S. J.Wilson and H. E.Heath: 5-Hydroxytryptamme-C14 platelet survival studies. J. Lab. clin. Med.62, 887 (1963).
Janeway, T. C., H. B.Richardson and E. A.Park: Experiments on the vasoconstrictor action of blood serum. Arch. intern. Med.21, 565–603 (1918).
Jaques, R., and M.Schachter: The presence of histamine, 5-hydroxytryptamine and a potent slow contracting substance in wasp venom. Brit. J. Pharmacol.9, 53–58 (1954).
Jensen, H.: Chemical studies on toad poisons.Bufo arenarum, Bufo regularis andXenopus laevis. J. Amer. chem. Soc.57, 1765–1768 (1935).
Jensen, K.: Paper chromatography determination of indoles in human cerebrospinal fluid. Acta neurol. scand.38, 278–284 (1962).
Johansson, S.-A.: 5-Hydroxytryptamine in burns. Acta physiol. scand.48, 126–132 (1960).
Johnsen jr., H.A., R. E.Smith and W.Simon: Diurnal variations in the excretion of urinary 5-hydroxyindoles. Clin. Res.6, 268–269 (1958).
Joyce, D.: Changes in the 5-hydroxytrvptamine content of rat, rabbit and human brain after death. Brit, J. Pharmacol.18, 370–380 (1962).
Joyce, D.: 5-Hydroxytryptamine content of glioma. Experientia (Basel)19, 187–188 (1963).
Jullien, A., J.Cardot and J.Ripplinger: Observations sur les substances cardioactives d’origine nerveuse chez les Crustacés Décapodes et chez les Mollusques Pulmonés. J. Physiol. (Paris)53, 381–382 (1961).
Kärki, N. T., R.Kuntzman and B. B.Brodie: Xorepinephrine and serotonin brain levels at various stages of ontogenetic development. Fed. Proc.19, 282 (1960b).
Kärki, N. T., R.Kuntzman and B. B.Brodie: Storage, synthesis, and metabolism of monoamines in the developing brain. J. Neurochem.9, 53–58 (1962).
Kärki, N. T., and M. K.Paasonen: Presence of 5-hydroxytryptamine after raunescine in blood plasma in vivo. Nature (Lond.)185, 109 (1960).
Kärki, N. T., M. K.Paasonen, and P.Peltola: Factors influencing the release of 5-hydroxytryptamine from the rabbit intestine into the venous blood. Ann. Med. exp. Fenn.38, 231–236 (1960a).
Kakimoto, Y., and M. D.Armstrong: On the identification of octopamine in mammals. J. biol. Chem.237, 422–427 (1962).
Karzel, K.: Einfluß des Mastzellentumors P-815 der Maus auf den 5-Hydroxytryptamin-Gehalt ihrer Organe. Med. exp.10, 115–118 (1964).
Kataoka, K.: Subcellular distribution of 5-hydroxytryptamine in the rabbit brain. Jap. J. Physiol.12, 623–638 (1962).
Katsh, S.: Serotonin and histamine in human ejaculate. J. Urol.81, 570–572 (1959).
Keller, R.: Histamin und 5-Hydroxytryptamin in den Gewebemastzellen der Albinoratte. Helv. physiol. Acta15, 371–375 (1957).
Kerkut, G. A., and G. A.Cottrell: Acetylcholine and 5-hydroxytryptamine in the snail brain. Comp. Biochem. Physiol.8, 53–63 (1963).
Kerkut, G. A., and M. A.Price: 6-HT in crab heart. Life Sciences No 2, 129–130 (1963).
Kerkut, G. A., and M. A.Price: Chromatographie separation of cardiaccelerators (6 HT and a mucopeptide) fromCarcinus heart. Comp. Biochem. Physiol.11, 45–52 (1964).
Kind, L. S., A.Burkhalter and R.Sherins: Increased lung serotonin and pulmonary edema in mice injected with antiserum to EHRLICH’S ascites tumor. Proc. Soc. exp. Biol. (N. Y.)108, 735–737 (1961).
Kindwall, E. P., L. O.Boréus and B.Westerholm: Failure to show change in rat tissue histamin and serotonin after rapid decompression. Amer. J. Physiol.203, 389–390 (1962).
Kirberger, E., u. L.Braun: Über das Vorkommen von 5-Hydroxytryptamin in der Walnuß (Juglans regia). Biochim. biophys. Acta (Amst.)49, 391–393 (1961).
Kirkwood, S., and L.Marion: The biogenesis of alkaloids. I. The isolation of N-methyl-tryptamine from barley. J. Amer. chem. Soc.57, 1765–1768 (1950).
Kiss, G., u. H.Michl: Über das Giftsekret der Gelbbauchunke,Bombina variegata L. Toxicon1, 33–39 (1962).
Kivalo, E., u. K.Rinne and H.Karinkanta: The effect of imipramine on the 5-hydroxytryptamine content and monoamine oxidase activity of the rat brain and on the excretion of 5-hydroxyindole acetic acid. J. Neurochem.8, 105–108 (1961).
Klambt, H.-D.: Die 2-Hydroxy-indol-3-essigsäure, ein pflanzliches Indolderivat. Naturwissenschaften46, 649 (1959).
Kleeberg, J., J.Boxer and E. J.Steiner: Studies on almonds. III. The serotonin content of dried sweet almonds. Arch. int. Pharmacodyn.144, 432–436 (1963).
Koch, G., u. G.Engelhardt: Über das argyrophüe Helle-Zellen-Organ in der Harnröhren-Schleimhaut des Säugetieres. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak.236, 463–473 (1959).
Kopin, I. J.: Tryptophan loading and excretion of 5-hydroxyindoleacetic acid in normal and schizophrenic subjects. Science129, 835–836 (1959).
Koren, Z., B.Eckstein, A.Brzezinski and F. G.Sulman: Adrenaline, noradrenaline and serotonin estimations in urine and amniotic fluid during delivery. J. Obstet. Gynaec. Brit. Cwlth68, 438–440 (1961).
Kuntzman, R., P. A.Shore, D.Bogdanski and B. B.Brodie: Microanalytical procedures for fluorometric assay of brain DOPA-5-HTP decarboxylase, norepinephrine and serotonin, and a detailed mapping of decarboxylase activity in brain. J. Neurochem.6, 226–232 (1961).
Kuriaki, K., et T.Inoue: Teneur en 5-hydroxytryptamine du placenta et des urines gravides et post-partum. C. R. Soc. Biol. (Paris)150, 1835–1837 (1956).
Leblanc., J.: Secretion and activity of histamine and serotonin during cold adaptation. Amer. J. Physiol.204, 520–522 (1963).
Legler, G., u. R.Tschesche: Isolierung von N-Methyltryptamin, 5-Methoxy-N-methyl-tryptamin und 5-Methoxy-N,N-dimethyltryptamin aus der Rinde von Piptadenia pere-grina Benth. Naturwissenschaften50, 94–95 (1963).
Lerner, A. B., and J. D.Case: Melatonin. Fed. Proc.19, 590–592 (1960).
Lerner, A. B., J. D.Case, K.Biemann, R. V.Heinzelman, J.Szmuszkovicz, W. C.Anthony and A.Krivis: Isolation of 5-methoxyindole-3-acetic acid from bovine pineal glands. J. Amer. chem. Soc.81, 5264 (1959a).
Lerner, A. B., J. D.Case, W.Mori and M.R.Wright: Melatonin in peripheral nerves. Nature (Lond.)188, 1821 (1959b).
Lerner, A. B., J. D.Case, and Y.Takahashi: Isolation of melatonin and 5-methoxyindole-3-acetic acid from bovine pineal glands. J. biol. Chem.235, 1992–1997 (1960).
Leroy, J. G.: 5-Hydroxytryptamine levels in brain of mice pretreated with α-methyl-dopa. Arch. int. Pharmacodyn.134, 492–496 (1961).
Levene, R. Z.: Mast cells and amines in normal ocular tissues. Invest Ophthal.1, 531–543 (1962).
Lewis, G. P.: 5-Hydroxytryptamine in the mast cells of the rat. In: G. P.Lewis, 5-Hydroxytryptamine, p. 26–31. London: Pergamon Press 1957.
Lewis, G. P.: 5-Hydroxytryptamine. J. Pharm. Pharmacol.10, 529–540 (1958).
Long, R. F.: Inhibition of 5-hydroxytryptamine uptake by plateletsin vitro andin vivo. Biochem. J.82, 4–5 P (1962).
Maas, J. W.: Neurochemical differences between two strains of mice. Nature (Lond.)197, 255–257 (1963).
Maass, A. R., and M. J.Nimmo: A new inhibitor of serotonin metabolism. Nature (Lond.)184, 547–548 (1959).
Macfarlane, P. S., C. E.Dalgliesh, R. W.Dutton, B.Lennox, L. M.Nyhus and A. N.Smith: Endocrine aspects of argentaffinoma, with special reference to the use of urinary 5-hydroxyindoleacetic acid estimation in diagnosis. Scot. med. J.1, 148–155 (1956).
Märki, F., A. V.Robertson and B.Witkop: Dehydrobufotenine, a novel type of tryciclic serotonin metabolite fromBufo marinus. J. Amer. ehem. Soc.83, 3341–3342 (1961).
Magus, R. D., F. W.Krause and B. E.Riedel: Release of thyroidal serotonin by reserpine, methyldopa and guanethidine. Biochem. Pharmacol.13, 115–117 (1964).
Mann, T.: Serotonin (5-hydroxytryptamine) in the male reproductive tract of the spiny dogfish. Nature (Lond.)188, 941–942 (1960).
Mann, T.: 5-Hydroxytryptamine in the spermatophoric sac of Octopus. Nature (Lond.)199, 1066–1067 (1963).
Mann, T., R. F.Seamark and D. F.Sharman: On the question of the occurrence and metabolism of 5-hydroxytryptamine and related indole compounds in mammalian semen. Brit. J. Pharmacol.17, 208–217 (1961).
Mansour, T. E., A. D.Lago and J. L.Hawkins: Occurrence and possible role of serotonin inFasciola hepatica. Fed. Proc.16, 319 (1957).
Marmo, E.: Psilocibina e psilocina: principi attivi dei funghi allucinogeni messicani. Clin. ter.18, 464–490 (1960).
Marshall, P. B.: Catechols and tryptamines in the “makote” banana (Musa paradisiaca). J. Pharm. Pharmacol.11, 639 (1959).
Mathias, A. P., D. M.Ross and M.Schachter: Identification and distribution of 5-hydroxytryptamine in a sea anemone. Nature (Lond.)180, 658–659 (1957).
Mathias, A. P., D. M.Ross and M.Schachter: Distribution of histamine, 5-hydroxytryptamine, tetramethylammonium, and other substances in coelenterates possessing nematocysts. J. Physiol. (Lond.)142, 56–57P (1958).
Mathias, A. P., D. M.Ross and M.Schachter: The distribution of 5-hydroxytryptamine, tetramethylammonium, homarine, and other substances in sea anemones. J. Physiol. (Lond.)151, 296–311 (1960).
Maynard, D. M., and J. H.Welsh: Neurohormones of the pericardial organs of brachyuran Crustacea. J. Physiol. (Lond.)149, 215–227 (1959).
Maynert, E. W., G. I.Klingman and H. K.Kaji: Tolerance to morphine. II. Lack of effects on brain 5-hydroxytryptamine and Ƴ-aminobutyric acid. J. Pharmacol. exp. Ther.135, 296–299 (1962).
Maynert, E. W., R.Levi and A. J. D. DeLorenzo: The presence of norepinephrine and 5-hydroxytryptamine in vesicles from disrupted nerve-ending particles. J. Pharmacol. exp. Ther.144, 385–392 (1964).
Maynert, E. W., R.Levi, and K.Kuriyama: Vesicles containing norepinephrine (NE) and 5-hydroxytryptamine (5-HT) from disrupted nerve-ending particles. Fed. Proc.23, 350 (1964).
Meier, H.: Serotonin (5-hydroxytryptamine) content of canine mastocytoma. Proc. Soc. exp. Biol. (N.Y.)100, 815–817 (1959).
Melching, H. J., H.Ernst u. H.Rössler: Untersuchungen über einen biologischen Strahlenschutz. XXXVI. Zum Stoffwechsel des 5-Hydroxytryptamins bei der Ganzkörperbestrahlung weiβer Mäuse und Ratten. Strahlentherapie113, 394–401 (1960).
Melmon, K., and A.Sjoerdsma: Serotonin in platelets. Lancet 1963II, 316–318.
Meng, K.: 5-Hydyroxytrptamin und Acetylcholin als Wirkungsantagonisten beim Helix-Herzen. Naturwissenschaften45, 470 (1958).
Mengel, CH. E., and M. G.Kelly: Biochemical and morphologic changes in a mast-cell neoplasm during treatment with cyclophosphamide. Cancer Res.21, 1545–1550 (1961).
Michaelson, I.A., and V. P.Whittaker: The distribution of 5-hydroxytryptamine in brain fractions. Biochem. Pharmacol.11, 505–506 (1962).
Michaelson, I.A., and V. P.Whittaker: The subcellular localization of 5-hydroxytryptamine in guinea-pig brain. Biochem. Pharmacol.12, 203–211 (1963).
Milne, M. D., M. A.Crawford, C. B.Girao and L.Loughridge: The excretion of indolyl-acetic acid and related indolic acids in man and the rat. Clin. Sci.19, 165–179 (1960).
Mirolli, M., and J. H.Welsh: The effects of reserpine and LSD on molluscs. In: D.Richter Ed., Comparative Neurochemistry, pp. 433–443. Oxford: Pergamon Press 1964.
Mörsdorf, K.: Spectrofluorometrische Bestimmung des 5-Hydroxytryptamingehaltes der Rattenpfote bei experimentellen „Entzündungen“. Med. exp. (Basel)1, 87–90 (1959).
Mörsdorf, K.: Die serotoninfreisetzende Wirkung einiger zur Auslösung experimenteller „Entzündungen“ verwendeter Stoffe in vitro. Med. exp. (Basel)4, 293–297 (1961).
Moore, K. E., and T. M.Brody: The effect of triethyltin on tissue amines. J. Pharmacol. exp. Ther.132, 6–12 (1961).
Moran, N. C., B.Uvnäs and B.Westerholm: Release of 5-hydroxytryptamine and histamine from rat mast cells. Acta physiol. scand.56, 26–41 (1962).
Moran, N. C.,and B.Westerholm: The influence of reserpine on 5-hydroxytryptamine and histamine content of rat mast cells and of some rat tissues. Acta physiol. scand.58, 20–29 (1963).
Nachmias, V. T.: Amine oxidase and 5-hydroxytryptamine in developing rat brain. J. Neurochem.6, 99–104 (1960).
Naers, K., and S.Schanche: Effect of reserpine on serotonin in rabbit serum. Nature (Lond.)117, 1130–1131 (1956).
Neumark, H.: Formation of serotonin in chopped green maize. Nature (Lond.)201, 527–528 (1964).
Nikkila, E. A.: Urinary excretion of the serotonin metabolite 5-hydroxyindole acetic acid in neurocirculatory asthenia. Acta med. scand.162, 231–235 (1958).
Nikodijević, B., and T.Trajkov: Mechanism of ulcerogenic action of 5-hydroxytryptamine in rat’s stomach. Arch. int. Pharmacodyn.148, 442–445 (1963).
O’connor, J. M.: Über den Adrenalingehalt des Blutes. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak.67, 195–232 (1912).
Olson, R. E., D.Gursey and J. W.Vester: Evidence for a defect in tryptophan metabolism in chronic alcoholism. New Engl. J. Med.263, 1169–1174 (1960).
Ono, S., L.Zompetti, P.Hagen and J.Furth: Relation of mastocytoma to mast cell leukemia, and of heparin, histamine and serotonin to mast cells. Blood14, 770–780 (1959).
Orchoff, A. P., u. S. S.Norkina: Über die Alkaloide vonArundo donax. Ber. dtsch. chem. Ges.68, 436–437 (1935).
Owman, CH.: On the presence of 5-hydroxytryptamine in pineal nerves. Biochem. Pharmacol.12, Suppl., 112 (1963).
Paasonen, M. K.: 5-Hydroxytryptamine in mammalian thyroid gland. Experientia (Basel)14, 95–96 (1958).
Paasonen, M. K., and N. J.Giarman: Brain levels of 5-hydroxytryptamine after various agents. Arch. int. Pharmacodyn.114, 189–200 (1958).
Paasonen, M. K., and N. T.Kärki: Increase of 5-hydroxytryptamine in the rat brain by raunescine. Brit. J. Pharmacol.14, 164–167 (1959).
Paasonen, M. K., N. T.Kärki, and S.Molkka: Influence of iproniazid and 5-hydroxytryptophan on the 5-hydroxytryptamine content in the gastro-intestinal tract and thyroid gland of rats. Ann. Med. exp. Fenn.39, 405–410 (1961).
Paasonen, M. K., P. D.Maclean and N. J.Giarman: 5-Hydroxytryptamine (serotonin, enteramine) content of structures of limbic system. J. Neurochem.1, 326–333 (1957).
Paasonen, M. K., and P.Peltola: The effect of methimazole and potassium thiocyanate on the 5-hydroxytryptamine content of the rat thyroid gland. Ann. Med. exp. Fenn.38, 228–230 (1960).
Paasonen, M. K., and M.Vogt: The effect of drugs on the amounts of substance P and 5-hydroxytryptamine in mammalian brain. J. Physiol. (Lond.)131, 617–626 (1956).
Pachter, I., D. E.Zacharius and O.Ribeiro: Indole alkaloids ofAcer saccharinum (the silver maple),Dictyoloma incanescens, Piptadenia colubrina, andMimosa hostilis. J. organ. Chem.24, 1285–1287 (1959).
Pachter, I. J.: A note on the occurrence of gramme inAcer rubrum L. J. Amer. pharm. Ass. (sci. Ed.)48, 670 (1959).
Pare, C. M. B., M.Sandler and R. S.Stacey: 5-Hydroxyindoles in mental deficiency. J. Neurol. Neurosurg. Psychiat.23, 341–346 (1960).
Parker-Williams, E. J., PH.Cohen, P.Waltrouse and F. H.Gartner: Platelet preservation studies using platelets labeled with C14-5-hydroxytryptamine. J. clin. Invest.42, 963 (1963).
Pabratt, J. R., and G. B.West: Tissue histamine and 5-hydroxytryptamine. J. Physiol. (Lond.)132, 40–41 P (1956a).
Pabratt, J. R., and G. B.West: Influence of age on tissue histamine and 5-hydroxytryptamine. J. Physiol. (Lond.)133, 71–72 P (1956b).
Pabratt, J. R., and G. B.West: 5-Hydroxytryptamine and tissue mast cells. J. Physiol. (Lond.)137, 169–178 (1957 a).
Pabratt, J. R., and G. B.West: Release of 5-hydroxytryptamine and histamine from tissues of the rat. J. Physiol. (Lond.)137, 179–192 (1957b).
Pabratt, J. R., and G. B.West: The relationship of 5-hydroxytryptamine to capillary permeability in the skin of the rat. J. Physiol. (Lond.)140, 105–112 (1958).
Peltola, P., and V.Leppänen: Studies on the excretion of 5-hydroxyindoleacetic acid. Ann. Med. intern. Fenn.49, 283–291 (1960).
Pepeu, G., and N. J.Giarman: Contrasting findings on serotonin (5-HT) in fetal life. Pharmacologist2, 91 (1960).
Pepeu, G., and N. J.Giarman: Serotonin in the developing mammal. J. gen. Physiol.45, 575–583 (1962).
Perman, E. S.: Observations on the effect of ethanol on the urinary excretion of histamine, 5-hydroxyindole acetic acid, catecholamines and 17-hydroxycorticosteroids in man. Acta physiol. scand.51, 62–67 (1961).
Perry, TH. L., S.Hansen and L. C.Jenkins: Aminé content of normal human cerebrospinal fluid. J. Neurochem.11, 49–53 (1964).
Perry, TH. L., N. F.Shaw and D.Walker: Apparent absence of amines in cerebrospinal fluid of phenylketonurics. Nature (Lond.)189, 926–927 (1961).
Philipps, J. H.: Isolation of active nematocysts ofMetridium senile and their chemical composition. Nature (Lond.)178, 932 (1956).
Phillips, A. W., H. R.Newcomb, J. E.Smith and R.Lachapelle: Serotonin in the small intestine of conventional and germ-free chicks. Nature (Lond.)192, 380 (1961).
Pigeaud, H., R.Burthiault, R.Bethoux et S.Nelken: Le dosage de l’acide 5-hydroxyindole-acétique au cours de la grossesse normale et dans les suites de couches immédiates. Gynéc. et Ostét.57, 415–425 (1958).
Pletscher, A.: Beeinflussung des 5-Hydroxytryptaminstoffwechsels im Gehirn durch Isonikotinsäurehydrazide. Experientia (Basel)12, 479–480 (1956 a).
Pletscher, A.: Wirkung von Isonicotinsäurehydraziden auf den o-Hydroxytryptaminstoffwechsel in vivo. Helv. physiol. Acta14, C76–79 (1956b).
Pletscher, A., W. P.Burkard, H.Bruderer and K. F.Gey: Decrease of cerebral 5-hydroxytryptamine and 5-hydroxyindoleacetic acid by an arylalkvlamine. Life Sci. No 11, 827–833 (1963).
Pletscher, A., P. A.Shore and B. B.Brodie: Serotonin as a mediator of reserpine action in brain. J. Pharmacol. exp. Ther.116, 84–89 (1956).
Pscheidt, G. R.: Serotonin and norepinephrine in chicken brain: distribution, normal level and effect of reserpine and monoamine oxidase. Fed. Proc.23, 305 (1964).
Pscheidt, G. R., and H. E.Himwich: Reserpine, monoamine oxidase inhibitors and distribution of biogenic amines in monkey brain. Biochem. Pharmacol.12, 65–72 (1963).
Pscheidt, G. R., C.Morpurgo and H. E.Himwich: Studies on norepinephrine and 5-hydroxytryptamine in various species. In: D.Richter Ed., Comparative Neurochemistry, pp. 401–412. Oxford: Pergamon Press 1964.
Pscheidt, G. R., C.Morpurgo, Chicken brain amines, with special reference to cerebellar norepinephrine. Life Sci., No 7, 524–526 (1963).
Purkhalskaia, E., and G. P.Menshikov: 5-Hydroxytryptamine fromHippophae rhamnoides as antitumoral agent in animal experiments. Biul. eksp. Biol. Med.50, 105–110 (1960).
Put, T. R., and L. A. H.Hogenhuis: Brain serotonin and thyroid function. Acta physiol. pharmacol. neerl.10, 343–352 (1962).
Quay, W. B.: Cytologie and metabolic parameters of pineal inhibition by continuous light in the rat (Battus norvegicus). Z. Zellforsch.60, 479–490 (1963a).
Quay, W. B.: Effect of dietary phenylalanine and tryptophan on pineal and hypothalamic serotonin levels. Proc. Soc. exp. Biol. (N.Y.)114, 718–721 (1963b).
Quay, W. B.: Circadian rhythm in rat pinael serotonin and its modifications by estrous cycle and photoperiod. Gen. comp. Endocr.3, 473–479 (1963 c).
Quay, W. B.: Circadian and estrous rhythms in pineal melatonin and o-hydroxy-indole-3-acetic acid. Proc. Soc. exp. Biol. (N.Y.)115, 710–713 (1964).
Quay, W. B., and A.Halevy: Experimental modification of the rat pineal’s content of serotonin and related indole amines. Physiol. Zool.35, 1–7 (1962).
Rand, M., and G.Reid: Source of “serotonin” in serum. Nature (Lond.)168, 385 (1951).
Rand, M., and G.Reid: On the presence in rabbit serum of thrombotonin (thrombocytin or serotonin). Aust. J. exp. Biol. med. Sci.30, 153–161 (1952).
Resnick, R. H., and S. J.Gray: Serotonin release bv hydrochloric acid. I. In vivo and in vitro demonstration. J. Lab. clin. Med.59, 462–468 (1962).
Resnick, R. H., G. T.Smith and S. J.Gray: Endocrine influences on tissue serotonin content of the rat. Amer. J. Physiol.201, 571–573 (1961).
Rice, W. G., and J.Mitchener: Histochemical evidence of 5-hydroxytryptamine in a dog mast cell tumour. Nature (Lond.)189, 767–768 (1961).
Riley, J. F.: Fluorescent mast cells in precancerous mouse skin. Experientia (Basel)14, 141 (1958).
Robertson, P.A., and W. V.Macfarlane: Pain-producing substances from the stinging bushLaportea moroides. Aust. J. exp. Biol. med. Sci.35, 381–394 (1957).
Robillard, E., and Y.Alarie: Mechanical properties and histamine and serotonin content of guinea pig lungs as influenced by microparticles inhalation. Canad. J. Biochem.41, 2177–2182 (1963).
Robinson, B., G. F.Smith, A. H.Jackson, D.Shaw, B.Frydman and V.Deulofeu: Dehydrobufotenin. Proc. Chem. Soc, August 1961, p. 310–311.
Robson, J. M., and J. B.Senior: The 5-hydroxytryptamine content of the placenta and foetus during pregnancy in mice. Brit. J. Pharmacol.22, 380–391 (1964).
Rodnight, R.: Separation and characterization of urinary indoles resembling 5-hydroxytryptamine and tryptamine. Biochem. J.64, 621–626 (1956).
Roos, B.-E.: The effect of monoamine oxidase inhibitors on the level of 5-hydroxyindoleacetic acid in human cerebrospinal fluid. Life Sci. No 1, 1–4 (1963).
Rosenberg, J. C., R. C.Lillehei, W. H.Moran and B.Zimmermann: Effect of endotoxin on plasma catechol amines and serum serotonin. Proc. Soc. exp. Biol. (N.Y.)102, 335–337 (1960).
Ryall, R. W.: Sub-cellular distribution of pharmacologically active substances in guinea-pig brain. Nature (Lond.)190, 680–681 (1962).
Ryall, R. W.: The subcellular distributions of acetylcholine, substance P, 5-hydroxytryptamine, γ-aminobutyric acid and glutamic acid in brain homogenates. J. Neurochem.11, 131–145 (1964).
Sanders, R., T. P.Waalkes, J. W.Gilbert jr. and L. L.Terry: Serotonin (5-hydroxytryptamine) and pulmonary thromboembolism. Surg. Gynec. Obstet.109, 455–459 (1959).
Sanner, E.: Studies on the excretion mechanism of serotonin (5-hydroxytryptamine) in the chicken kidney. Acta physiol. scand.58, 330–341 (1963).
Sanner, E., and B.Wortman: Tubular excretion of serotonin (5-hydroxytryptamine) in the chicken. Acta physiol. scand.55, 319–324 (1962).
Sanyal, R. K., and G. B.West: The relationship of histamine and 5-hydroxytryptamine to anaphylactic shock in different species. J. Physiol. (Lond.)144, 525–531 (1958).
Saxena, P. R., K.Kishor, M. C.Pant and K. P.Bhargava: Pharmacologically active constituents ofGirardinia heterophylla. J. Pharm. Pharmacol.16, 361 (1964).
Schanberg, S. M., and N. J.Giarman: Drug-induced alterations in the subcellular distribution of 5-hydroxytryptamine in rat’s brain. Biochem. Pharmacol.11, 187–194 (1962).
Schanberg, S. M., C. M.Mckean and N. J.Giarman: A mechanism of the indole defect in experimental phenylketonuria. Fed. Proc.21, 269 (1962).
Schindler, R., M.Day and G. A.Fischer: Culture of neoplastic mast cells and their synthesis of 5-hydroxytryptamine and histamine in vitro. Cancer Res.19, 47–51 (1959).
Schone, H.-H., u. E.Lindner: Die Wirkung des N-[3′-Phenyl-propyl-(2′)]-l,l-dipenyl-propyl-(3)-amins auf den Stoffwechsel von Serotonin und Noradrenalin. Arzneimittel-Forsch.10, 583–585 (1960).
Schulz, H., H.Strobach u. E.Hiepler: Serotoninbestimmungen an Thrombocyten und an Fraktionen von Thrombocyten. Klin. Wschr.42, 232–236 (1964).
Schwabe, U., D.Heyl, H. J.Hildebrandt u. T.Hukuhara: Alkylphosphatvergiftung und 5-Hydroxytryptamin-Stoffwechsel des Zentralnervensystems. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak.241, 254–259 (1961).
Schwemmle, K., E.Schmid, F.Scheiffarth, L.Zicha u. E.Schichor: Zur Frage der gegenseitigen Beziehungen zwischen adrenocorticotropem Hormon bzw. Glucocorticoiden und dem Serotonin-Stoffwechsel. Arzneimittel-Forsch.11, 616–619 (1961).
Sherwood W. K.,: Experience with “BGE”, a naturally occurring indole compound. J. nerv. ment. Dis.125, 490–491 (1957).
Shore, P. A., and B. B.Brodle: LSD-like effects elicited by reserpine in rabbits pretreated with iproniazid. Proc. Soc. exp. Biol. (N.Y.)94, 433–435 (1957).
Shore, P. A., A.Pletscher, E. G.Tomich, R.Kuntzman and B. B.Brodie: Release of blood platelet serotonin by reserpine and lack of effect on bleeding time. J. Pharmacol. exp. Ther.117, 232–236 (1956).
Simon, A.: Über die Pharmakologie der gefäβverengernden Stoffe der Blutseren. I. Naunyn-Schmiedeberg’s Arch. exp. Path. Pharmak.190, 273–279 (1938).
Simon, A.: Über die Pharmakologie der gefäβverengernden Stoffe der Blutseren. II. Naunvn-Schmiedeberg’s Arch. exp. Path. Pharmak.192, 701–707 (1939).
Simon, S. E., K. D.Cairncross, D. G.Satchell, W. S.Gay and S.Edwards: The toxicity ofOctopus maculosus Hoyle venom. Arch. int. Pharmacodyn.149, 318–329 (1964).
Sjoerdsma, A., J. A.Oates and L.Gillespie Jr.: Quantitation of monoamineoxidase inhibition produced with various drugs in man. Proc. Soc. exp. Biol. (N.Y.)103, 485–487 (1960).
Sjoerdsma, A., J. A.Oates, P.Zaltzman and S.Udenfriend: Identification and assay of urinary tryptamine: application as an index of monoamine oxidase inhibition in man. J. Pharmacol. exp. Ther.126, 217–222 (1959).
Sjoerdsma, A., T. P.Waalkes and H.Weissbach: Serotonin and histamine in mast cells. Science125, 1202–1203 (1957 L.).
Sjoerdsma, A., H.Weissbach, L. L.Terry and S.Udenfriend: Further observations on patients with malignant carcinoid. Amer. J. Med.23, 5–15 (1957b).
Sjoerdsma, A., H.Weissbach, and S.Udenfriend: A clinical, physiologic and biochemical study of patients with malignant carcinoid. Amer. J. Med.20, 520–532 (1956).
Skillen, R. G., C. H.Thienes, J.Cangelosi and L.Strain: Brain 5-hydroxytryptamine in ozone-exposed rats. Proc. Soc. exp. Biol. (N.Y.)108, 121–122 (1961).
Skillen, R. G., C. H.Thienes and L.Strain: 5-Hydroxytryptamine, 5-hydroxytryptophan decarboxylase and monoamine oxidase in hearts of normal, thyroid fed and propylthiouracil-fed male and female rats. Endocrinology70, 743–747 (1962).
Smith, D. E., and Y. S.Lewis: Preparation and effects of an anti-mast cell serum. J. exp. Med.113, 683–692 (1961).
Smith, G., and A. N.Smith: The role of serotonin in experimental pulmonary embolism. Surg. Gynec. Obstet.101, 691–700 (1955).
Smith, S. E.: The pharmacological actions of 3,4-dihydroxyphenyl-α-methylalanine (α-methyl-dopa), an inhibitor of 5-hydroxytryptophan decarboxylase. Brit. J. Pharmacol.15, 319–327 (1960).
Smith, S. E., R. S.Stacey and I. M.Young: 5-Hydroxytryptamine and o-hydroxytryptophan decarboxylase activity in the developing nervous system of rats and guinea-pigs. Biochem. Pharmacol.8, 32 (1961).
Snow, P. J. D., J. E.Lenhard-Jones, G.Curzon and R. S.Stacey: Humoral effects of metastasing carcinoid tumours. Lancet 1955II, 1004–1009.
Sochor, P., and D.Lakatua: Daily variations of 5-hydroxyindoleacetic acid urinarv excretion. Fed. Proc.23, 437 (1964).
Southern, A. L.: Functioning metastatic bronchial carcinoid with elevated levels of serum and cerebrospinal fluid serotonin and pituitary adenoma. J. clin. Endocr.20, 298–305 (1960).
Spector, S., R.Kuntzman, P. A.Shore and B. B.Brodie: Evidence for release of brain amines by reserpine in presence of monoamine oxidase inhibitors: implication of monoamineoxidase in norepinephrine metabolism in brain. J. Pharmacol. exp. Ther.130, 256–261 (1960).
Sprince, H., C. M.Parker, D.Jameson, J. T.Dawson Jr., M.Knowlton and F. C.Dohan: Detection and isolation of indoleacetamide from human urine: results with schizophrenic and normal subjects. J. Lab. clin. Med.57, 763–770 (1961).
Stacey, R. S.: 5-Hydroxytryptamine and other pharmacologically active substances in the central nervous system. Acta physiol. neerl.8, 222–239 (1959).
Stacey, R. S.: Uptake of 5-hydroxytryptamine by platelets. Brit. J. Pharmacol.16, 284–295 (1961).
Stacey, R. S., and T. J.Sullivan: Effect of diet and antibiotics on intestinal 5-hydroxytryptamine. J. Physiol. (Lond.)137, 63–64 P (1957).
Stacey, R. S., and I. M.Young: Concentration of 5-hydroxytryptamine in the small intestine and platelets of the developing guinea pig. Biochem. Pharmacol.13, 129–134 (1964).
Stock, K., u. E. O.Westermann: Biogene Amine im Fettgewebe. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak.246, 15–16 (1963).
Stock, K., u. E. O.Westermann: Concentration of norepinephrine, serotonin, and histamine, and of amine-metabolizing enzymes in mammalian adipose tissue. Lipid Res.4, 297–304 (1963).
Stolk, A.: Mast cell reaction during chemical skin carcinogenesis of the lizard Lacerta agilis. Experientia (Basel)19, 20–21 (1963).
Stromberg, V. L.: The isolation of bufotenine fromPiptadenia peregrina. J. Amer. chem. Soc.76, 1707 (1954).
Sturm jr., A., u. G.Stüttgen: Nachweis von 5-Hydroxytryptophan in menschlichen Mastzellen. Klin. Wschr.40, 199–201 (1962).
Sullivan, T. J.: The effect of diet on the 5-hydroxytryptamine content of the small intestine and of other organs in rats and mice. Brit. J. Pharmacol.15, 513–519 (1960).
Sullivan, T. J.: Effect of antibiotics on the 5-hydroxytryptamine content of the small intestine and other organs in rats and mice. Brit. J. Pharmacol.16, 90–98 (1961).
Supek, Z., M.Jovic u. S.Keckes: Der 5-Hydroxytryptamin-Gehalt der Haut der Ratte bei experimenteller Entzündung. Arzneimittel-Forsch.11, 132–133 (1961).
Tabachnick, I. A., and A. A.Rubin: Some relationships between peripheral monoamine oxidase inhibition and brain 5-hydroxytryptamine levels in brain. Proc. Soc. exp. Biol. (N.Y.)101, 435–437 (1959).
Telford, J. M., and G. B.West: The effects of corticosteroids and related compounds on the histamine and 5-hydroxytryptamine content of rat tissues. Brit. J. Pharmacol.15, 532–539 (1960).
Todrick, A., M.Dick and A. C.Tait: Effect of reserpine in therapeutic dosage on excretion of 5-hydroxyindoleacetic acid. Brit. med. J. 1958I, 496–499.
Toh, C. C.: Release of 5-hydroxytryptamine (serotonin) and histamine from platelets by tissue extracts. J. Physiol. (Lond.)133, 402–411 (1956).
Toh, C. C.: Effect of temperature on the 5-hydroxytryptamine (serotonin) content of tissues. J. Physiol. (Lond.)151, 410–415 (1960).
Towne, J. C., E.Fenster, J. O.Sherman and T.Schaefer: Estimation of serotonin and catechol amines in acetone solution. Fed. Proc.21, 420 (1962).
Towsend, E. E., J. G.Katis and T. L.Sourkes: Effect of tryptophan deficiency in rat on liver tryptophan peroxidase-oxidase (TPO) and urinary 5-hydroxy-3-indoleacetic acid (HIAA). Fed. Proc.17, 324 (1958).
Turner, W. J., and E. A.Mauss: Serotonin (5-hydroxytryptamine) and acetylcholine in human ventricular and spinal fluids. Arch. gen. Psychiat.1, 646–650 (1959).
Twarog, B. M.: Response of a molluscan smooth muscle to acetylcholine and to 5-hydroxytryptamine. J. cell. comp. Physiol.44, 141–164 (1954).
Twarog, B. M., and I. H.Page: Serotonin content of some mammalian tissues and urine. Amer. J. Physiol.175, 157–161 (1953).
Tyce, G. M., E. V.Flock and CH. A.Owen: 5-Hydroxindoles in the rat after hepatectomy. Fed. Proc.22, 632 (1963).
Tyce, G. M., G. H. C.Stobie, E. V.Flock and J. L.Bollman: 5-Hydroxytryptamine content of the brain after hepatectomy. Fed. Proc.21, 301 (1962).
Tyce, G. M., G. H. C.Stobie, E. V.Flock and J. L.Bollman: 5-Hydroxytryptamine in the gastrointestinal tract after intestinal obstruction and hepatectomy. Proc. Soc. exp. Biol. (N.Y.)115, 1068–1072 (1964).
Tyler jr., V. E.: Occurrence of serotonin in a hallucinogenic mushroom. Science128, 718 (1958).
Tyler jr., V. E., and D.Groger: Occurrence of 5-hydroxytryptamine and 5-hydroxytryptophan inPanaeolus sphinctrinus. J. pharm. Sci.53, 462 (1964).
Udenfriend, S., W.Lovenberg and A.Sjoerdsma: Physiologically active amines in common fruits and vegetables. Arch. Biochem. Biophys.85, 487–490 (1959).
Udenfriend, S., E.Titus and H.Weissbach: The identification of 5-hydroxy-3-indoleacetic acid in normal urine and a method for its assay. J. biol. Chem.216, 499–505 (1955).
Udenfriend, S., H.Weissbach and D. F.Bogdanski: Biochemical findings relating to the action of serotonin. Ann. N.Y. Acad. Sci.66 (3), 602–608 (1957).
Udenfriend, S., B.Witkop, B. G.Redfield and H.Weissbach: Studies with reversible inhibitors of monoamine oxidase: harmaline and related compounds. Biochem. Pharmacol.1, 160–165 (1958).
Utley, J. D.: Gamma aminobutyric acid and 5-hydroxytryptamine concentrations in neurons and glial cells in the medial geniculate body of the cat. Biochem. Pharmacol.12, 1228–1230 (1963).
Uuspää, V. J.: The 5-hydroxytryptamine content of the brain and some other organs of the hedgehog (Erinaceus europaeus) during activity and hibernation. Experientia (Basel)19, 156–158 (1963).
Uuspää, V. J., and V. I.Uuspää: VANE’S rat fundus strip method in determination of 5-hydroxytryptamine. Ann. Acad. Sci. fenn. A, IV,60, 1–17 (1962).
Varagic., V., M.Krstic., S.Stepanovic and S.Hajdukovic: The effect of γ-irradiation on the amount of 5-hydroxytryptamine in the gut and spleen in the early phase after irradiation. Experientia (Basel)19, 647–648 (1963).
Vialli, M., e V.Erspamer: Ricerche sul secreto delle cellule enterocromaffini. IX. Intorno alla natura chimica della sostanza specifica. Boll. Soc. med.-chir. Pavia51, 1111–1116 (1937).
Waalkes, T. PH., and H.Coburn: The role of platelets and the release of serotonin and histamine during anaphylaxis in the rabbit. J. Allergy30, 394–407 (1959).
Waalkes, T. PH., and H.Coburn: The role of histamine and serotonin during anaphylaxis in the mouse. J. Allergy31, 151–161 (1960a).
Waalkes, T. PH., and H.Coburn: Serotonin, histamine, and the Arthus phenomenon. J. Allergy31, 181–184 (1960b).
Waalkes, T. PH., H.Coburn, and L. L.Terry: The effect of reserpine on histamine and serotonin. J. Allergy30, 408–414 (1959).
Waalkes, T. PH., A.Sjoerdsma, C. R.Creveling, H.Weissbach and S.Udenfriend: Serotonin, norepinephrine and related compounds in bananas. Science127, 648–650 (1958).
Walaszek, E. J. and L. G.Abood: Fixation of 5-hydroxytryptamine by brain mitochondria. Proc. Soc. exp. Biol. (N.Y.)101, 37–40 (1959).
Wang, H. L., V. H.Harwalker and H. A.Waisman: Effect of dietary phenylalanine and triptophan on brain serotonin. Arch. Biochem. Biophys.96, 181–184 (1962).
Wang, H. L., V. H.Harwalker and H. A.Waisman: Influence of dietary phenylalanine and tryptophan on tissue serotonin. Fed. Proc.20, 6 (1961).
Weissbach, H., T. PH.Waalkes and S.Udenfriend: Presence of serotonin in lung and its implication in the anaphylactic reaction. Science125, 235–236 (1957).
Weissbach, H., T. PH.Waalkes and S.Udenfriend: A simplified method for measuring serotonin in tissues; simultaneous assay of both serotonin and histamine. J. biol. Chem.230, 865–871 (1958).
Weissman, A., and K. F.Finger: Effects of benzquinamide on avoidance behavior and brain amine levels. Biochem. Pharmacol.11, 871–880 (1962).
Welsh, J. H.: Neurohormones of invertebrates. I. Cardio-regulators ofCyprina andBuccinum. J. Mar. biol. Ass. U. Kingd.35, 193–201 (1956).
Welsh, J. H.: Serotonin as a possible neurohumoral agent: evidence obtained in lower animals. Ann. N.Y. Acad. Sci.66 (3), 618–630 (1957).
Welsh, J. H.: Evidence for 5-HT granules in molluscan ganglia. Anat. Rec.132, 516 (1958).
Welsh, J. H.: 5-Hydroxytryptamine in coelenterates. Nature (Lond.)186, 811–812 (1960).
Welsh, J. H.: The quantitative distribution of 5-hydroxytryptamine in the nervous system, eyes and other organs of some vertebrates. In: D.Richter Ed., Comparative Neurochemistry, pp. 355–366. Oxford: Pergamon Press 1964.
Welsh, J. H., and C. S.Batty: 5-Hydroxytryptamine content of some arthropod venoms and venom-containing parts. Toxicon1, 165–173 (1963).
Welsh, J. H., and M.Moorhead: Identification and assay of 5-hydroxytryptamine in molluscan tissues by fluorescence method. Science129, 1491–1492 (1959).
Welsh, J. H., and M.Moorhead: The quantitative distribution of 5-hydroxytryptamine in the invertebrates, especially in their nervous system. J. Neurochem.6, 146–169 (1960).
West, G. B.: Tryptamines in edible fruits. J. Pharm. Pharmacol.10, 589–590 (1958a).
West, G. B.: Comparison of the release of histamine and 5-hydroxytryptamine from tissues of the rat, mouse and hamster. Int. Arch. Allergy13, 336–347 (1958b).
West, G. B.: Tryptamine in tomatoes. J. Pharm. Pharmacol.11, 319–320 (1959a).
West, G. B.: Indole dcrivatives in tomatoes. J. Pharm. Pharmacol.11, 275–277 T (1959b).
West, G. B.: Carcinoid tumours and pineapples. J. Pharm. Pharmacol.12, 768 (1960).
White, E. P.: Alkaloids of the leguminosae. VIII–XIII. N. Z. J. Sci. Technol., Sect. B25, 137–162 (1944).
Whittaker, V. P.: The isolation and characterization of acetylcholine-containing particles from brain. Biochem. J.72, 694–706 (1959).
Whittaker, V. P.: The subcellular localization of transmitter substances in the central nervous system. Biochem. Pharmacol.5, 392–398 (1961).
Whittaker, V. P.: Sub-cellular distribution of 5-hydroxytryptamine in guinea pig brain. Nature (Lond.)195, 1100 (1962).
Wiegand, R. G., and J. E.Perry: Effect of L-Dopa and N-methyl-N-benzyl-2-propynyl-amine. HC1 on dopa, dopamine, norepinephrine, epinephrine and serotonin levels in mouse brain. Biochem. Pharmacol.7, 181–186 (1961).
Wiegand, R. G., and E.Scherfling: Determination of 5-hydroxvtryptophan and serotonin. J. Neuro-chem.9, 113–114 (1962).
Wieland, TH., u. W.Motzel: Über das Vorkommen von Bufotenin im gelben Knollenblätterpilz. Justus Liebigs Ann. Cliem.581, 10–16 (1953).
Wier, J. K., and V. E.Tyler jr.: Quantitative determination of serotonin in Panaeolus species. J. pharm. Sci.52, 419–422 (1963).
Wilkinson, S.: 5-Methoxy-N-methyltryptamine: a new indole alkaloid fromPhalaris arundinacea L. J. chem. Soc.2, 2079–2081 (1958).
Wurtman, R. J., J.Axelrod and J. E.Fischer: Melatonin synthesis in the pineal gland: effect of light mediated by the sympathetic nervous system. Science143, 1328–1330 (1964).
Yeh, S. D. J., J. D.Solomon and B. F.Chow: Influence of vitamin B 6 on tissue serotonin levels in rats. Fed. Proc.18, 357 (1959).
Yurashevskii, M. K.: Alkaloids ofGirgensohnia diptera, family Chenopodiaceae. J. gen. Chem. (U.S.S.R.)10, 1781–1783 (1940).
Yuwiller, A., and R. T.Louttit: Effects of phenylalanine diet on brain serotonin in the rat. Science134, 831–832 (1961).
Zarafonetis, C. J. D., and J. P.Kalas: Serotonin, catecholamines and amine oxidase activity in the venom of certain reptiles. Amer. J. med. Sci.240, 764–768 (1960).
Zbinden, G., A.Pletscher u. A.Studer: xAlimentäre Beeinflussung der enterochromaffinen Zellen und des 5-Hydroxvtryptamin-Gehaltes von Gehirn und Darm. Z. ges. exp. Med.129, 615–620 (1958).
Zieher, L. M., and E. DeRobertis: Subcellular localization of 5-hydroxytryptamine in rat brain. Biochem. Pharmacol.12, 596–598 (1963).
Zucker, M. B., B. K.Friedman and M. M.Rapport: Identification and quantitative determination of serotonin (5-hydroxytryptamine) in blood platelets. Proc. Soc. exp. Biol. (N.Y.)85, 282–285 (1954).
Zucker, M. B., L.Hellman and B.Zumoff: Rapid disappearance of C14-labeled serotonin from platelets in patients with carcinoid syndrome. J. Lab. clin. Med.63, 137–146 (1964).
Zucker, M. B., and M. M.Rapport: Identification and quantitative determination of serotonin (5-hydroxytryptamine) in platelets, the source of serum serotonin. Fed. Proc.13, 170–171 (1954).
- Vittorio Erspamer
Search author on:PubMed Google Scholar
Editor information
Rights and permissions
Copyright information
© 1966 Springer-Verlag, Berlin · Heidelberg
About this chapter
Cite this chapter
Erspamer, V. (1966). Occurrence of indolealkylamines in nature. In: Erspamer, V. (eds) 5-Hydroxytryptamine and Related Indolealkylamines. Handbook of Experimental Pharmacology/Handbuch der experimentellen Pharmakologie, vol 19. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-85467-5_4
Download citation
Publisher Name:Springer, Berlin, Heidelberg
Print ISBN:978-3-642-85469-9
Online ISBN:978-3-642-85467-5
eBook Packages:Springer Book Archive
Share this chapter
Anyone you share the following link with will be able to read this content:
Sorry, a shareable link is not currently available for this article.
Provided by the Springer Nature SharedIt content-sharing initiative
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.